drugset / Trial / NCT00792688
Efficacy Study of GLYC-101 to Evaluate Outcomes After Laser Ablation
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objectives of this study are to evaluate safety and efficacy of topically applied Glucoprime gel (GLYC-101, 0.1% and GLYC-101, 1.0%) in promoting wound healing in cosmetic surgery patients undergoing Carbon Dioxide Laser Skin Resurfacing (CO2 LSR) of the lower eyelids. The study will observe the effects of the topical agent over the course of 1 month following the initial treatment.
Timeline
- Start
- 2008-10
- Primary completion
- 2010-01
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | beta-glucan | Other / unclassified | 0.1 % | Topical |
| Subject | beta-glucan | Other / unclassified | 1 % | Topical |
Indications
No indication recorded.